Floatz logo

Lorazepam

Bariatric Surgery Candidate

University of California, DavisSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
89/ 100

Competitive context

21 Active assets in the Bariatric Surgery Candidate cohort.

Asset / SponsorPhaseRating
LIDOCAINE
Instituto Mexicano del Seguro Social
Phase 4BBB
RAMIFENTANYL
Hospital dos Lusíadas
Phase 4BBB
Amoxicillin
Fatih Sultan Mehmet Training and Research Hospital
Phase 4BBB
Liraglutide
University of Sao Paulo General Hospital
Phase 4BB
Metformin
RenJi Hospital
Phase 4BB

View all 42 →

Same molecule, other indications

Lorazepam is also rated in:

schizoaffective disorderDormant
BBB
Indicative ·
73 / 100
View asset →
PsychosesDormant
BB
Indicative ·
70 / 100
View asset →
bipolar disorderDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →